BioNTech vets start "virtual clinic" for cancer surveillance Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

Mon T W Th F 10 August, 2026

One night, one room: the founders, scientists and investors behind the Endpoints 11, together in Boston this September. Reserve your spot now and save with the early bird rate.

presented by The de­bate of dura­bil­i­ty in nAMD

news Silence spells out Phase 2 success for gene-silencing drug in rare blood cancer Exclusive: BioNTech vets get $25M seed funding for virtual cancer surveillance startup

Aug 19 1:00 pm ET From pilots to production: AI across R&D, safety, regulatory, and clinical sponsored by IBM Aug 27 12:00 pm ET Same molecule, different paths: Where value goes in cross-border dealmaking in a new era sponsored by PharmCube Sep 03 11:00 am ET How leading pharma organizations are putting AI agents to work sponsored by Medable

Scientist, Drug Discovery Data for AI/ML D. E. Shaw Research New York, NY, USA Machine Learning Researchers and Engineers D. E. Shaw Research New York, NY, USA Recruit talent with Endpoints Careers Contact Meg Estacio: mestacio@endpointsnews.com

in case you missed it 1. BINSA is back: Senate bill emerges, adding pressure on Treasury to screen China biotech deals 2. FDA to hold adcomm for Grail cancer test that failed in large, randomized trial 3. ‘A chilling effect’: China biotech will slow as it nears R&D frontier, Pfizer’s Baum predicts 4. News Briefing BioMarin discontinues rare disease drug; CSL and Arcturus split up 5. Updated: BlossomHill, Latigo cap four-IPO week with combined $496M haul 6. Peer Review Jennifer Taubert announces retirement from J&J; Takeda's global TYK2 leader exits 7. Exclusive: FDA outlines expedited IND pilot plans, seeking to pick up to 10 programs by year's end 8. Sexmaxxing in the city: The SF biohackers injecting peptides for optimal horniness The San Francisco Standard 9. Pfizer grapples with ‘a world of hurt’ after Covid triumph

.